SPEXIS AG, a clinical-stage biopharmaceutical company, announced that its CXCR4 inhibitor balixafortide demonstrated synergistic efficacy in combination with docetaxel compared to either drug alone...
Ear care company Eosera, known for carrying the most comprehensive and effective lineup of at-home ear care solutions, is pleased to announce it has...
Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, announced that the...
IVERIC bio, Inc. and DelSiTech Ltd, announced an exclusive global license agreement providing Iveric Bio with the right to develop and commercialize new formulations...
Intravacc, a world leading contract development and manufacturing organization (CDMO) of preventive and therapeutic vaccines and the German Center for Neurogenerative Diseases (DZNE), have...
